Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does early growth hormone therapy prevent glucocorticoid-associated growth retardation in children with JIA?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. MacRae VE et al. (2006) Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review). Intl J Mol Med 18: 1011–1018

    CAS  Google Scholar 

  2. De Benedetti F et al. (1997) Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99: 643–650

    Article  CAS  Google Scholar 

  3. Tynjälä et al. (2006) Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 65: 1044–1049

    Article  Google Scholar 

  4. Beukelman TG and Cron RQ (2005) JIA-associated growth failure and exogenous growth hormone therapy. Pediatr Rheumatol Online J 3: 99–108

    Google Scholar 

  5. Bechtold S et al. (2007) Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study. J Clin Endocrionol Metab 92: 3013–3018

    Article  CAS  Google Scholar 

  6. Bechtold S et al. (2005) Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoids treatment: a controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 90: 3168–3173

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Bryony Mearns, Associate Editor, Nature Clinical Practice. The Practice Point commentary reflects the views of the authors and not of the US Government. LG Rider is supported by the intramural research program of NIEHS, NIH, and EW Leschek is supported by the extramural research program of NIDDK, NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa G Rider.

Ethics declarations

Competing interests

LG Rider has received grant/research support from National Institute of Environmental Health Sciences, NIH. EW Leschek has received grant/research support from National Institute of Diabetes and Digestive and Kidney Diseases, NIH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rider, L., Leschek, E. Does early growth hormone therapy prevent glucocorticoid-associated growth retardation in children with JIA?. Nat Rev Rheumatol 4, 394–395 (2008). https://doi.org/10.1038/ncprheum0845

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0845

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing